methacrylamido propanediol | 131808-79-2

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: methacrylamido propanediol
• 英文别名: N-(1,3-dihydroxypropan-2-yl) methacrylamide；N-(1,3-dihydroxypropan-2-yl)-2-methylprop-2-enamide
• CAS: 131808-79-2
• 化学式: C₇H₁₃NO₃
• 分子量: 159.185
• InChiKey: BADXLDYEYMCSEN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.8
• 重原子数：
  11
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  69.6
• 氢给体数：
  3
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  methacrylamido propanediol 、 原甲酸三乙酯 在 对甲苯磺酸 作用下， 以 水 为溶剂， 生成 N-(2-ethoxy-1,3-dioxan-5-yl)-2-methylprop-2-enamide 、 N-(2-ethoxy-1,3-dioxan-5-yl)-2-methylprop-2-enamide
  参考文献：
  名称：

  带有侧链环原酸酯基的酸不稳定的热响应性聚（甲基）丙烯酰胺的水溶液性质

  摘要：

  具有侧链六元环原酸酯基的一系列聚（甲基）丙烯酰胺衍生物，即聚（N-（2-烷氧基-1,3-二恶烷-5-基）甲基丙烯酰胺）和聚（N-（2-已合成并表征了烷氧基-1,3-二氧杂环己烷-5-基）丙烯酰胺）。这些聚合物之间的区别在于烷基取代基（R 3）的类型，侧链原酸酯侧基的立体化学结构（反式与顺式）以及主链结构（聚甲基丙烯酰胺与聚丙烯酰胺）。通过多种方法研究了这些聚合物的水溶液性质和pH依赖性水解行为，包括浊度法，荧光探针，DSC，11 H NMR，显微镜和光散射。结果表明，除了Pt NPM以外，这些聚合物都可以在低温下溶于水，并且所有水溶性聚合物在不同的较低临界溶液温度（LCST）下都具有热敏感性，并且在弱酸性条件下易水解。聚合物的热敏性能和酸引发的水解行为都与聚合物结构密切相关。通常，聚甲基丙烯酰胺显示出比​​聚丙烯酰胺更高的浊点（CP）。此外，具有较大R 3和反式构型的聚合物具有较低的CP和

  DOI：

  10.1021/ma902227g
• 作为产物：
  描述：

  methacrylamido-di-O-trimethyl-silyl-propanediol 在 2,2,2-三氟乙醇 作用下， 生成 methacrylamido propanediol
  参考文献：
  名称：

  Anteunis, M. J. O.; Becu, Chr., Bulletin des Societes Chimiques Belges, 1987, vol. 96, # 7, p. 555 - 556

  摘要：

  DOI：

文献信息

• COLORED CURABLE COMPOSITION, COLOR FILTER AND SOLID-STATE IMAGING DEVICE
  申请人：FUJIFILM Corporation

  公开号：EP2270593A1

  公开（公告）日：2011-01-05

  A colored curable composition including: (A) a pigment dispersion containing (a-1) a pigment, (a-2) a compound having a pigment mother nucleus structure and an amino group in a molecule, and (a-3) a resin having an acid group and a polymerizable group; (B) an oxime ester initiator; and (C) a polymerizable compound.

  一种可着色固化组合物，包括：(A) 颜料分散体，其中含有 (a-1) 颜料，(a-2) 具有颜料母核结构且分子中含有氨基的化合物，以及 (a-3) 具有酸性基团和可聚合基团的树脂；(B) 肟酯引发剂；以及 (C) 可聚合化合物。
• RADIATION CURABLE POLYURETHANE RESIN FOR INK JET INK
  申请人：AGFA NV

  公开号：EP3717540A1

  公开（公告）日：2020-10-07
• LASER-DECOMPOSABLE RESIN COMPOSITION AND LASER-DECOMPOSABLE PATTERN-FORMING MATERIAL AND FLEXOGRAPHIC PRINTING PLATE PRECURSOR OF LASER ENGRAVING TYPE USING THE SAME
  申请人：SUGASAKI Atsushi

  公开号：US20080057437A1

  公开（公告）日：2008-03-06

  A laser-decomposable resin composition of the invention contains a polyurethane resin having a structure wherein an aromatic group is directly connected to a urethane bond.
• NEAR-INFRARED ABSORPTIVE COMPOSITION, NEAR-INFRARED CUT FILTER USING NEAR-INFRARED ABSORPTIVE COMPOSITION, METHOD FOR MANUFACTURING NEAR-INFRARED CUT FILTER, AND CAMERA MODULE AND METHOD FOR MANUFACTURING CAMERA MODULE
  申请人：FUJIFILM CORPORATION

  公开号：US20150124152A1

  公开（公告）日：2015-05-07

  Provided is a near-infrared absorptive compositions which having excellent near-infrared shielding property even if they are formed into thin films, being able to apply, and inhibited transmittance of visible light loss and transmittance loss after postbaking even if they contain a higher proportion of solids such as copper complexes. The near-infrared absorptive composition comprising a copper complex, a polyfunctional polymerizable compound and a solvent, wherein the near-infrared absorptive composition has a solids content of 35 to 90% by mass.
• PROTECTED ANTIBODY-DRUG AND APTAMER-DRUG CONJUGATES
  申请人：Kosak Kenneth Michael

  公开号：US20210198671A1

  公开（公告）日：2021-07-01

  This is a Continuation in Part (CIP), and Nonprovisional U.S. Patent Application of Provisional U.S. Patent Application No. 62/786,340, filed Dec. 29, 2018, (herein called App. 62/786,340), the entire contents, including suitable methods and examples, and references therein which are hereby incorporated by reference as if fully set forth herein. All patent applications, patents, and publications, including supplementary materials, and additional references therein, that are cited herein, are hereby incorporated herein by reference in their entireties, except for any conflicting definitions, subject matter disclaimers or disavowals, and except to the extent that the incorporated material is inconsistent or in conflict with the express disclosures herein, in which case the language in this disclosure controls. For this invention, certain useful compositions and synthesis methods, and all categories of active agents, ligands, all intercalators of nucleic acids and peptides, any antibodies, any nucleic acids, including carrier nucleic acid compositions, peptide nucleic acids (PNA) and derivatized nucleic acids, splicing RNA (spRNA), DNAzymes, any polymers, targeting moieties, target substances including cancer cells, disease microorganisms and biomarkers, coupling agents and functional groups, are all suitably modified as needed. All compositions that would be useful for this invention after suitable modification, defined herein, including crRNAs, sgRNAs, any CRISPR proteins and compositions, any zinc finger proteins and compositions, any TALEN proteins and compositions and any suitable derivatives thereof.